Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility
about
The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormoneCalcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns.Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera.Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.Metabolism and biological activity of parathyroid hormone in renal cortical membranes.Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitoninEffects of hepatectomy, nephrectomy, and nephrectomy/uremia on the metabolism of parathyroid hormone in the rat.Metabolism of parathyroid hormone by isolated rat Kupffer cells and hepatocytesCytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal formsResponsiveness of neoplastic and hyperplastic parathyroid tissues to calcium in vitro.Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.Heterogeneity of parathyroid hormone. Clinical and physiologic implications.Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Use of reversed-phase liquid chromatography.Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
P2860
Q24622214-87D6F4AD-3AF6-41C1-AD30-65463777EC41Q34464656-7C0E0FA6-3DAB-4BC2-A59D-A16D59DAC339Q34470774-E6170754-DB1B-45D9-9D2C-075B28020778Q34722880-1B8AF033-BB17-4CE2-9213-C8F70CDCA231Q35195994-F238DD2A-43F1-4D73-BCB8-E975BC48F509Q35204163-6274542A-35DD-4B5D-993A-9ED4C8847A89Q36995418-3F866818-D4EC-45C2-ACEA-DD620238F612Q36995456-EA6939FF-5FA0-4A4C-8D51-EBFBC457A9AEQ37023083-F9509253-E5DF-4173-8561-457C93A609D4Q37030942-43E104A3-5E38-404E-9A47-09F8DDE256E2Q37049054-1D4BB1EE-1696-4B03-AB6D-B146DEDA701AQ40372629-4C1A1E10-D626-40FD-BACA-D621A7F0BBDBQ46337816-89F7CEF3-DD51-4A9A-AFE5-E69137A98405Q46551085-9819ACD8-A6D7-4246-8117-EBECB0F42F17
P2860
Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility
description
1973 nî lūn-bûn
@nan
1973 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@ast
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@en
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@nl
type
label
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@ast
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@en
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@nl
prefLabel
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@ast
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@en
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@nl
P2093
P2860
P356
P1476
Etiology of hyperparathyroidis ...... of parathyroid suppressibility
@en
P2093
Fournier AE
Furszyfer J
Goldsmith RS
Johnson WJ
Sizemore GW
P2860
P304
P356
10.1172/JCI107161
P407
P577
1973-01-01T00:00:00Z